Tiannan Guo received clinical medicine training (1999-2006) at Huazhong University of Science and Technology and studied biology (2001-2005) at Wuhan University before his PhD training in cancer proteomics (2008-2012) with Dr. Newman Sze at Nanyang Technological University and Dr. Oi Lian Kon at National Cancer Centre Singapore. In 2012, he started postdoctoral training with Dr. Ruedi Aebersold at ETH Zurich. He joined the Westlake Institute for Advanced Studies, Westlake University, in August 2017 as a tenure-track assistant professor, becoming a tenured associate professor in January 2023. He directs the Westlake Center for Intelligent Proteomics and is an associate faculty member of the Research Center for Industries of the Future. He serves on several journals including Mol Cell Proteomics, Cell Systems, Cell Rep Med, Scientific Data, Genomics Proteomics Bioinformatics, Proteomics, and Clinical Proteomics.
The team aims to develop mass spectrometry-based proteomics technologies and AI models to understand the proteome complexity, with a focus on understudied proteins and spatial and temporal dynamics of proteomes. We also work on clinical translation of the proteomics discoveries, technologies and AI models, facilitating disease diagnosis, treatment and drug discovery.